MCID: PLM018
MIFTS: 37

Pulmonary Sclerosing Hemangioma malady

Categories: Cancer diseases, Respiratory diseases

Aliases & Classifications for Pulmonary Sclerosing Hemangioma

About this section

Aliases & Descriptions for Pulmonary Sclerosing Hemangioma:

Name: Pulmonary Sclerosing Hemangioma 10 12 36 65
 
Pneumocytoma 10

Classifications:



External Ids:

Disease Ontology10 DOID:5766
MeSH36 D047868
SNOMED-CT59 707365008
NCIt42 C5656
UMLS65 C1334455

Summaries for Pulmonary Sclerosing Hemangioma

About this section
MalaCards based summary: Pulmonary Sclerosing Hemangioma, also known as pneumocytoma, is related to niemann-pick disease and cowden syndrome 3. An important gene associated with Pulmonary Sclerosing Hemangioma is NKX2-1 (NK2 Homeobox 1), and among its related pathways are Surfactant metabolism and Cell adhesion_Endothelial cell contacts by junctional mechanisms. Affiliated tissues include lung, bone and brain, and related mouse phenotypes are renal/urinary system and endocrine/exocrine gland.

Related Diseases for Pulmonary Sclerosing Hemangioma

About this section

Graphical network of the top 20 diseases related to Pulmonary Sclerosing Hemangioma:



Diseases related to pulmonary sclerosing hemangioma

Symptoms for Pulmonary Sclerosing Hemangioma

About this section

Drugs & Therapeutics for Pulmonary Sclerosing Hemangioma

About this section

Drugs for Pulmonary Sclerosing Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 32)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Doxorubicinapproved, investigationalPhase 3158223214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
2
IfosfamideapprovedPhase 33713778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide
 
Ifosfamide (JAN/USP/INN)
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
3
DoxilApproved June 1999Phase 3158231703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
4lenograstimPhase 31134
5Topoisomerase InhibitorsPhase 34081
6Isophosphamide mustardPhase 3371
7Anti-Bacterial AgentsPhase 39140
8Antibiotics, AntitubercularPhase 35971
9
Ritonavirapproved, investigationalPhase 2850155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
10
IndinavirapprovedPhase 2110150378-17-95362440
Synonyms:
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide
(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-pentonamide
(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide
150378-17-9
157810-81-6
157810-81-6 (sulfate (1:1) (salt))
166746-42-5
1c6y
1hsg
1hsh
1k6c
1sdt
1sdu
1sdv
1sgu
216884-06-9
2avo
2avs
2avv
2bpx
AC-20034
AC1L1U7I
AKOS000280989
BIDD:GT0378
BIDD:PXR0141
C07051
 
C36H47N5O4
CHEBI:44032
Compound J
Crixivan
Crixivan (TM)
DB00224
IDV
Indinavir
Indinavir (*1:1 Sulfate salt*)
Indinavir [USAN]
Indinavir sulfate
Indinavir sulphate
Indinavir, Sulfate (1:1)
L 735524
L-735 524
L-735,524
L-735524
LS-173382
MK-639
MolPort-000-883-804
N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE
NCGC00159460-02
NSC697197
Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide
Propolis+Indinavir
RS-253
UNII-9MG78X43ZT
indinavir
11Liver ExtractsPhase 23572
12Anti-Infective AgentsPhase 217220
13Antiviral AgentsPhase 28071
14Anti-Retroviral AgentsPhase 22794
15Protease InhibitorsPhase 24558
16HIV Protease InhibitorsPhase 24558
17Cytochrome P-450 Enzyme InhibitorsPhase 23036
18Cytochrome P-450 CYP3A InhibitorsPhase 21421
19ColaNutraceuticalPhase 2, Phase 11768
20
FluorouracilapprovedPhase 1168451-21-83385
Synonyms:
1-fluoro-1h-pyrimidine-2,4-dione
1004-03-1
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 FU Lederle
5 FU medac
5 Fluorouracil
5 Fluorouracil biosyn
5 HU Hexal
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-Fluoropyrimidine-2,4-dione
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5-HU Hexal
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-fluoropyrimidine-2,4(1H,3H)-dione
5-fluorouracil
51-21-8
5FU
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AI3-25297
AKOS000119162
AKOS003237897
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
BSPBio_002048
C07649
C4H3FN2O2
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
CPD0-1327
CPD000038082
CSP Brand of Fluorouracil
Carac
Carac (TN)
Carzonal
Cinco FU
Cytosafe
D005472
D00584
DB00544
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
EINECS 200-085-6
EU-0100536
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
FT-0082524
FU
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoro-Uracile ICN
Fluoro-uracile
Fluoro-uracilo
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracil [USAN:INN:BAN:JAN]
 
Fluorouracil-GRY
Fluorouracile
Fluorouracile Dakota
Fluorouracile [DCIT]
Fluorouracilo
Fluorouracilo Ferrer Far
Fluorouracilo [INN-Spanish]
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
Ftoruracil
Gry Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
LS-153
Lopac-F-6627
Lopac0_000536
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
NCI60_001652
NINDS_000054
NSC 19893
NSC-19893
NSC19893
Neocorp Brand of Fluorouracil
Neofluor
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
SPECTRUM1500305
STK297802
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
Spectrum_000841
T5233394
TL8006093
Teva Brand of Fluorouracil
Timazin
U 8953
U-8953
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
Ulup
WLN: T6MVMVJ EF
ZINC00897110
biosyn Brand of Fluorouracil
fluorouracil
inhibits thymilidate synthetase
medac Brand of Fluorouracil
nchembio.90-comp3
nchembio809-comp6
ribosepharm Brand of Fluorouracil
tetratogen
21
Belinostatapproved, investigationalPhase 141
Synonyms:
Beleodaq
 
Belinostat
PXD 101
22Analgesics, Non-NarcoticPhase 15184
23Interleukin-2Phase 1487
24AnalgesicsPhase 19358
25VaccinesPhase 16085
26Peripheral Nervous System AgentsPhase 118510
27AntimetabolitesPhase 19454
28AndrogensPhase 11162
29Antimetabolites, AntineoplasticPhase 15770
30Histone Deacetylase InhibitorsPhase 1532
31Immunologic FactorsPhase 118483
32Immunosuppressive AgentsPhase 110422

Interventional clinical trials:

idNameStatusNCT IDPhase
1Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaCompletedNCT00002764Phase 3
2Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the LungCompletedNCT00503295Phase 2
3External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain MetastasesRecruitingNCT00637637Phase 2
4Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsCompletedNCT00413322Phase 1
5Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1

Search NIH Clinical Center for Pulmonary Sclerosing Hemangioma


Cochrane evidence based reviews: pulmonary sclerosing hemangioma

Genetic Tests for Pulmonary Sclerosing Hemangioma

About this section

Anatomical Context for Pulmonary Sclerosing Hemangioma

About this section

MalaCards organs/tissues related to Pulmonary Sclerosing Hemangioma:

33
Lung, Bone, Brain, Breast, Cervix, Neutrophil, Endothelial

Animal Models for Pulmonary Sclerosing Hemangioma or affiliated genes

About this section

MGI Mouse Phenotypes related to Pulmonary Sclerosing Hemangioma:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.5AR, AXIN1, CTNNB1, CTNND1
2MP:00053798.0AR, CDH1, CTNNB1, CTNND1, NKX2-1
3MP:00020068.0AR, CDH1, CTNNB1, CTNND1, NKX2-1
4MP:00028737.9AR, AXIN1, CDH1, CTNNB1, NKX2-1
5MP:00053897.8AR, AXIN1, CDH1, CTNNB1, NKX2-1
6MP:00053857.6AR, AXIN1, CDH1, CTNNB1, NKX2-1
7MP:00053817.3AR, AXIN1, CDH1, CTNNB1, CTNND1, NKX2-1
8MP:00053847.2AR, AXIN1, CDH1, CTNNB1, CTNND1, NKX2-1
9MP:00107686.4AR, AXIN1, CDH1, CTNNB1, CTNND1, NKX2-1

Publications for Pulmonary Sclerosing Hemangioma

About this section

Articles related to Pulmonary Sclerosing Hemangioma:

(show top 50)    (show all 58)
idTitleAuthorsYear
1
Actinic keratosis in China: big numbers and small percentages. (27206355)
2016
2
Molecular mechanisms of GLUT4 regulation in adipocytes. (24656589)
2014
3
Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid. (23233540)
2013
4
Mandibular metastasis of adenocarcinoma from prostate cancer: case report according to epidemiology and current therapeutical trends of the advanced prostate cancer. (24212997)
2013
5
Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding. (23014115)
2013
6
Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. (22991301)
2013
7
Episodic facial sweating. Frey Syndrome. (23454328)
2013
8
SNX17 protects integrins from degradation by sorting between lysosomal and recycling pathways. (22492727)
2012
9
The ubiquitin ligase mLin41 temporally promotes neural progenitor cell maintenance through FGF signaling. (22508726)
2012
10
Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome. (22732336)
2012
11
Cancer stem cell and embryonic development-associated molecules contribute to prognostic significance in ovarian cancer. (22080880)
2012
12
Atypical epidermolysis bullosa simplex with a missense keratin 14 mutation p.Arg125Cys. (21967011)
2011
13
Bullous pemphigoid in a patient with suspected non-Herlitz junctional epidermolysis bullosa. (20456391)
2010
14
Lynch syndrome: presenting with gastrocolic fistula. (21568151)
2010
15
Co-purified gelatinases alter the stability and biological activities of human plasma fibronectin preparations. (19909400)
2010
16
Accurate, Large-Scale Genotyping of 5HTTLPR and Flanking Single Nucleotide Polymorphisms in an Association Study of Depression, Anxiety, and Personality Measures. (19541292)
2009
17
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas. (19774387)
2009
18
Report on varicocele and infertility. (19007639)
2008
19
Non-synonymous polymorphisms in the circadian gene NPAS2 and breast cancer risk. (17453337)
2008
20
Is arteriovenous shunting involved in the development of varicosities? A study of the intraluminal pressure and oxygen content in varicose veins. (18467623)
2008
21
Effect of preoperative transcatheter arterial chemo-embolization on activity of cell proliferation in Wilms; tumor]. (18275125)
2008
22
Inhibition of NF-kappa B activity enhanced apoptosis induced by matrine in hepatocellular carcinoma cells]. (18171526)
2007
23
Establishment of a cultivated human conjunctival epithelium as an alternative tissue source for autologous corneal epithelial transplantation. (16936093)
2006
24
Selective inhibition of cyclooxygenase (COX)-2 inhibits endothelial cell proliferation by induction of cell cycle arrest. (15472909)
2005
25
Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. (15231648)
2004
26
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. (14675724)
2004
27
Combinatory chemical and biological approaches to investigate metal elements in agricultural runoff water. (14964369)
2004
28
Alcohol and illicit drug dependence. (15748041)
2004
29
Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. (12661993)
2003
30
Successful induction and maintenance of long-term remission in a child with chronic relapsing autoimmune hemolytic anemia using rituximab. (12959862)
2003
31
Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes. (11700305)
2002
32
Fatty acid binding protein 2 and insulin resistance. (11422402)
2001
33
Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones. (10671948)
2000
34
Exposure of human epidermal keratinocyte cell cultures to sulfur mustard promotes binding of complement C1q: implications for toxicity and medical countermeasures. (11428648)
2000
35
Acute stress disorder and subsequent post-traumatic stress disorder in a group of exposed disaster workers. (10945140)
2000
36
Differential expression of Ca(2+)-binding proteins on follicular dendritic cells in non-neoplastic and neoplastic lymphoid follicles. (10487838)
1999
37
Nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in the isolated guinea-pig atria. (10189110)
1999
38
Association between plasma HDL-cholesterol concentration and Taq1B CETP gene polymorphism in non-insulin-dependent diabetes mellitus. (9469586)
1998
39
Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an alpha1-->3 fucosyltransferase (Fuc-T VII). (8940172)
1996
40
Development of the aortic vessel wall as defined by vascular smooth muscle and extracellular matrix markers. (8812136)
1996
41
Somatostatin antisense oligodeoxynucleotide-mediated stimulation of lymphocyte proliferation in culture. (8612489)
1996
42
Cellular localization of inflammatory cytokines in human glomerulonephritis. (8032526)
1994
43
Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. (1320020)
1992
44
In situ characterization of cells in periapical granuloma by monoclonal antibodies. (3477750)
1987
45
Lymphomatoid granulomatosis. (7070449)
1982
46
Fletcher factor deficiency: family study and detection. (4821398)
1974
47
Flotation, displacement, and decubitus ulcer. (5187944)
1968
48
Cytological changes preceding the appearance of in situ carcinoma of the uterine cervix. (14352168)
1955
49
The Radical Cure of Gonorrhoeal Iritis. (19981310)
1920
50
OPHTHALMIA NEONATORUM. (18167853)
1919

Variations for Pulmonary Sclerosing Hemangioma

About this section

Expression for genes affiliated with Pulmonary Sclerosing Hemangioma

About this section
Search GEO for disease gene expression data for Pulmonary Sclerosing Hemangioma.

Pathways for genes affiliated with Pulmonary Sclerosing Hemangioma

About this section

Pathways related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

(show all 34)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.7NKX2-1, SFTPB
29.5CTNNB1, CTNND1
39.5CTNNB1, CTNND1
49.4AXIN1, CTNNB1
59.4AXIN1, CTNNB1
69.3AR, CTNNB1
79.2CDH1, CTNND1
89.2CDH1, CTNND1
99.1CDH1, CTNNB1
109.1CDH1, CTNNB1
119.1CDH1, CTNNB1
129.1CDH1, CTNNB1
13
Show member pathways
9.0CDH1, CTNNB1
149.0AXIN1, CTNNB1, CTNND1
158.8AR, AXIN1, CTNNB1
168.7CDH1, CTNNB1, CTNND1
178.7CDH1, CTNNB1, CTNND1
188.7CDH1, CTNNB1, CTNND1
198.7CDH1, CTNNB1, CTNND1
208.7CDH1, CTNNB1, CTNND1
21
Show member pathways
8.7CDH1, CTNNB1, CTNND1
228.7CDH1, CTNNB1, CTNND1
23
Show member pathways
8.6CDH1, CTNNB1, CTNND1
248.6AXIN1, CDH1, CTNNB1
258.6AXIN1, CDH1, CTNNB1
268.6AXIN1, CDH1, CTNNB1
278.6AXIN1, CDH1, CTNNB1
28
Show member pathways
8.6AXIN1, CDH1, CTNNB1
298.6AXIN1, CDH1, CTNNB1
30
Show member pathways
8.5AR, CDH1, CTNNB1
318.5AR, CDH1, CTNNB1
328.5AR, CDH1, CTNNB1
33
Show member pathways
8.2AXIN1, CDH1, CTNNB1, CTNND1
348.0AR, AXIN1, CDH1, CTNNB1

GO Terms for genes affiliated with Pulmonary Sclerosing Hemangioma

About this section

Cellular components related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell cortexGO:00059389.4AXIN1, CTNNB1

Biological processes related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

(show all 16)
idNameGO IDScoreTop Affiliating Genes
1forebrain developmentGO:003090010.1CTNNB1, NKX2-1
2organ morphogenesisGO:000988710.0NKX2-1, SFTPB
3Leydig cell differentiationGO:00333279.9AR, NKX2-1
4beta-catenin destruction complex disassemblyGO:19048869.8AXIN1, CTNNB1
5canonical Wnt signaling pathwayGO:00600709.7AXIN1, CTNNB1
6positive regulation of MAPK cascadeGO:00434109.7AR, CTNNB1
7androgen receptor signaling pathwayGO:00305219.7AR, CTNNB1
8pituitary gland developmentGO:00219839.7CDH1, NKX2-1
9cellular response to indole-3-methanolGO:00716819.7CDH1, CTNNB1
10cellular response to lithium ionGO:00712859.7CDH1, CTNNB1
11neuron migrationGO:00017649.6CTNNB1, NKX2-1
12single organismal cell-cell adhesionGO:00163379.6CTNNB1, CTNND1
13lung developmentGO:00303249.3CTNNB1, NKX2-1
14positive regulation of gene expressionGO:00106289.0AR, CTNNB1, NKX2-1
15adherens junction organizationGO:00343328.8CDH1, CTNNB1, CTNND1
16positive regulation of transcription, DNA-templatedGO:00458938.3AR, AXIN1, CDH1, CTNNB1

Molecular functions related to Pulmonary Sclerosing Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1beta-catenin bindingGO:00080139.3AR, AXIN1

Sources for Pulmonary Sclerosing Hemangioma

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet